144 related articles for article (PubMed ID: 922789)
1. [Mazindol in the treatment of obesity in diabetics (author's transl)].
Felt V; Nedvídková J
Cas Lek Cesk; 1977 Sep; 116(39):1214-7. PubMed ID: 922789
[No Abstract] [Full Text] [Related]
2. Double-blind clinical evaluation of mazindol (42-548) in obese diabetics.
Bandisode MS; Boshell BR
Curr Ther Res Clin Exp; 1975 Dec; 18(6):816-24. PubMed ID: 813947
[No Abstract] [Full Text] [Related]
3. [Mazindol in the treatment of obese diabetic patients].
Dolecek R; Reil P; Skarpová O; Závada M
Vnitr Lek; 1976 Aug; 22(8):798-804. PubMed ID: 788327
[No Abstract] [Full Text] [Related]
4. [The clinical evaluation of teronac (Mazindol) in the treatment of children with obesity. Part I. Effect of the drug on somatic patterns and exercise capacity (author's transl)].
Gołebiowska M; Chlebna-Sokoł D; Mastalska A; Zwaigzne-Raczyńska J
Przegl Lek; 1981; 38(2):311-4. PubMed ID: 7017826
[No Abstract] [Full Text] [Related]
5. [Treatment of obesity with mazindol (author's transl)].
Escher M
Schweiz Rundsch Med Prax; 1976 Jun; 65(24):751-4. PubMed ID: 981189
[No Abstract] [Full Text] [Related]
6. [Clinical use of mazindol in the treatment of essential obesity].
Guazzelli R; Piazzini M; Conti C; Papi L; Strazzulla G; Matassi L
Clin Ter; 1987 Mar; 120(5):385-91. PubMed ID: 2953538
[No Abstract] [Full Text] [Related]
7. [Treatment of obesity with a non-amphetamine anorexigenic agent (author's transl)].
Riesco J; Troncoso G; Costamaillere L; Rodríguez J
Rev Med Chil; 1977 Jun; 105(6):375-9. PubMed ID: 331428
[No Abstract] [Full Text] [Related]
8. [Comparative trial on the effects of diet, mazindol, and placebo in the treatment of exogenous obesity (author's transl)].
Mies R
Med Klin; 1976 Nov; 71(46):2013-6. PubMed ID: 995040
[TBL] [Abstract][Full Text] [Related]
9. [Mazindol, an anorectic of a new series, in the treatment of obesity (author's transl)].
Dolecek R
Cas Lek Cesk; 1975 Feb; 114(8):249-54. PubMed ID: 1095197
[No Abstract] [Full Text] [Related]
10. [Clinical evaluation of Teronac (mazindol) in the treatment of obesity in children. Part II. Anorectic properties and side effects (author's transl)].
Gołebiowska M; Chlebna-Sokół D; Kobierska I; Konopińska A; Małek M; Mastalska A; Zwaigzne-Raczyńska J
Przegl Lek; 1981; 38(3):355-8. PubMed ID: 7017827
[No Abstract] [Full Text] [Related]
11. A multi-centre general practice trial of mazindol in the treatment of obesity.
Maclay WP; Wallace MG
Practitioner; 1977 Mar; 218(1305):431-4. PubMed ID: 322112
[No Abstract] [Full Text] [Related]
12. [Treatment of simple obesity with mazindol under sanatorium conditions].
Hasik J; Gawlak E; Tycowa M
Pol Tyg Lek; 1980 Nov; 35(45):1729-31. PubMed ID: 7012806
[No Abstract] [Full Text] [Related]
13. [Clinical trial with a nonamphetaminic anoretic].
Campagnoli M
Rev Iber Endocrinol; 1976; 23(137):463-83. PubMed ID: 794978
[TBL] [Abstract][Full Text] [Related]
14. [Long-term treatment of patients with obesity using mazindol and a reducing diet].
van Seters AP; Bouwhuis-Hoogerwerf ML; Goslings BM; van Nieuwkoop L; van Slooten H; Struijk-Wielinga T
Ned Tijdschr Geneeskd; 1982 May; 126(22):990-4. PubMed ID: 7110390
[No Abstract] [Full Text] [Related]
15. [Use of teronak for the treatment of obesity with and without diabetes mellitus].
Egart FM; Korotkova VD
Probl Endokrinol (Mosk); 1980; 26(2):16-20. PubMed ID: 7375451
[TBL] [Abstract][Full Text] [Related]
16. [Mazindol (AN-448): a new non-amphetamine anorectic in the treatment of exogenous obesity].
Delitala G; Alagna S; Masala A
Clin Ter; 1977 Jun; 81(6):547-54. PubMed ID: 884939
[No Abstract] [Full Text] [Related]
17. The effect of an anorectic agent (Mazindol) on control of obese diabetics.
Sanders M; Breidahl H
Med J Aust; 1976 Oct; 2(15):576-7. PubMed ID: 994969
[TBL] [Abstract][Full Text] [Related]
18. AN 448 Sandoz (Mazindol) in the treatment of obesity.
Wallace AG
Med J Aust; 1976 Mar; 1(11):343-5. PubMed ID: 775265
[TBL] [Abstract][Full Text] [Related]
19. [Anorexiant drugs in the ambulant treatment of obese patients (author's transl)].
Jenny S; Zimmermann KG; Radielovic P; Bühlmann AA
Schweiz Rundsch Med Prax; 1976 Jul; 65(28):874-8. PubMed ID: 1005298
[No Abstract] [Full Text] [Related]
20. Letter: Drugs in obesity.
Jackson WP; Vinik AI
S Afr Med J; 1975 May; 49(20):803. PubMed ID: 1098170
[No Abstract] [Full Text] [Related]
[Next] [New Search]
